These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 21536742)

  • 21. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
    Divito SJ; Aasebø AT; Matos TR; Hsieh PC; Collin M; Elco CP; O'Malley JT; Bækkevold ES; Reims H; Gedde-Dahl T; Hagerstrom M; Hilaire J; Lian JW; Milford EL; Pinkus GS; Ho VT; Soiffer RJ; Kim HT; Mihm MC; Ritz J; Guleria I; Cutler CS; Clark RA; Jahnsen FL; Kupper TS
    J Clin Invest; 2020 Sep; 130(9):4624-4636. PubMed ID: 32516138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.
    Askew D; Pareek TK; Eid S; Ganguly S; Tyler M; Huang AY; Letterio JJ; Cooke KR
    Blood; 2017 Jan; 129(2):246-256. PubMed ID: 28064242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
    Morris ES; MacDonald KP; Hill GR
    Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
    Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
    Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2 regulates CD4
    Tsai JJ; Velardi E; Shono Y; Argyropoulos KV; Holland AM; Smith OM; Yim NL; Rao UK; Kreines FM; Lieberman SR; Young LF; Lazrak A; Youssef S; Fu YY; Liu C; Lezcano C; Murphy GF; Na IK; Jenq RR; Hanash AM; Dudakov JA; van den Brink MRM
    Blood; 2018 Dec; 132(26):2763-2774. PubMed ID: 30381375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.
    Wang H; Asavaroengchai W; Yeap BY; Wang MG; Wang S; Sykes M; Yang YG
    Blood; 2009 Apr; 113(15):3612-9. PubMed ID: 19211507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
    Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.
    van Balen P; van der Zouwen B; Kruisselbrink AB; Eefting M; Szuhai K; Jordanova ES; Falkenburg JHF; Jedema I
    Front Immunol; 2018; 9():331. PubMed ID: 29535719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
    Matta BM; Reichenbach DK; Zhang X; Mathews L; Koehn BH; Dwyer GK; Lott JM; Uhl FM; Pfeifer D; Feser CJ; Smith MJ; Liu Q; Zeiser R; Blazar BR; Turnquist HR
    Blood; 2016 Jul; 128(3):427-39. PubMed ID: 27222477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
    Aizawa K; Peltier D; Matsuki E; Toubai T
    Transfus Apher Sci; 2022 Apr; 61(2):103405. PubMed ID: 35210194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LPS
    Jeljeli M; Chêne C; Chouzenoux S; Thomas M; Segain B; Doridot L; Nicco C; Batteux F
    Front Immunol; 2021; 12():670776. PubMed ID: 34413847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
    Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
    Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.
    Chopra M; Biehl M; Steinfatt T; Brandl A; Kums J; Amich J; Vaeth M; Kuen J; Holtappels R; Podlech J; Mottok A; Kraus S; Jordán-Garrote AL; Bäuerlein CA; Brede C; Ribechini E; Fick A; Seher A; Polz J; Ottmüller KJ; Baker J; Nishikii H; Ritz M; Mattenheimer K; Schwinn S; Winter T; Schäfer V; Krappmann S; Einsele H; Müller TD; Reddehase MJ; Lutz MB; Männel DN; Berberich-Siebelt F; Wajant H; Beilhack A
    J Exp Med; 2016 Aug; 213(9):1881-900. PubMed ID: 27526711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
    Betts BC; Bastian D; Iamsawat S; Nguyen H; Heinrichs JL; Wu Y; Daenthanasanmak A; Veerapathran A; O'Mahony A; Walton K; Reff J; Horna P; Sagatys EM; Lee MC; Singer J; Chang YJ; Liu C; Pidala J; Anasetti C; Yu XZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1582-1587. PubMed ID: 29382747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.
    Miyata M; Matsuki E; Ichikawa K; Takehara T; Hosokawa Y; Sekiguchi E; Peltier D; Reddy P; Ishizawa K; Watanabe M; Toubai T
    Blood Adv; 2023 Nov; 7(22):6936-6948. PubMed ID: 37748044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
    Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].
    Yang K; Liu QF; Fan ZP; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):547-52. PubMed ID: 17605863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.